Sun Pharma faces the heat as Q4 profit halves; Valia’s role reduced

- A ₹1,085 crore one-time charge following a governance scandal hit profit
- Sudhir Valia, brother-in law of founder Dilip Shanghvi, will become a non-executive director from whole-time director